The Rise of Altcoins Won't Eclipse Bitcoin Just Yet
Sure different forms of cryptocurrencies may be surging, but you might not want to write-off Bitcoin...at least not yet!
Jake Yocom-Piatt, the project lead at fellow cryptocurrency Decred, told Cheddar that the newly-discovered coins might not be eclipsing Bitcoin anytime soon.
“For all we know Bitcoin may fall, but right now it’s the dominant cryptocurrency and it looks like it’s going to stay that way, at least for the short-term,” he said. “Whether that’s going to remain the case in the longer term it’s hard to say.”
But investors are exploring other options. Tron, which launched last September, has leapt into the top 10 in terms of market cap in just four months. Its most recent surge was helped by founder Justin Sun’s announcement this week that Tron will announce a partnership with a “prestigious public” company next week.
For full interview [click here](https://cheddar.com/videos/will-altcoins-eclipse-bitcoin).
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
